Could a common diabetes pill protect new Moms' hearts after risky pregnancies?
NCT ID NCT06785116
Summary
This study is testing if a medication called dapagliflozin, often used for diabetes, can help reduce future heart risks in women who had high blood pressure during pregnancy. Researchers will enroll 200 women who recently gave birth and had conditions like pre-eclampsia. Participants will take either the real medication or a placebo pill daily for six months to see if it improves heart health markers like blood pressure and heart structure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.